Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OXN PR for Pain in Bladder Pain Syndrome
NCT01197261Phase 2Completed
- Sponsor
- Mundipharma
- Start
- Sep 2010
- Primary completion
- Mar 2013
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of oxycodone + naloxone in bladder pain syndrome (BPS), sponsored by Mundipharma. Started Sep 2010; status: completed.
02
Drugs
oxycodone + naloxone
03
Conditions
bladder pain syndrome (BPS)
Beyond the preview
Go deeper on NCT01197261.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197261.